Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Humood Al Shmrany

Showing results (11-20 of 41) with videos related to

Pageof 5
Sort By:
International Journal of Pharmaceutics|February 1, 2026
Poly-ε-caprolactone nanoparticles in breast cancer therapy: bridging bench research and clinical potentialMuskan Leharwani, Urushi Rehman, Taha Alqahtani, et al.
Clinical and Translational Medicine|January 6, 2026
Stimulator of interferon genes (STING)-activating nanomedicines: Translating innate immune modulation into effective therapy for triple-negative breast cancerHarshita Singhai, Taha Alqahtani, Humood Al Shmrany, et al.
Drug Development Research|April 20, 2026
Artificial Intelligence in Drug Discovery and Development: Transforming Pharmaceutical InnovationMohd Shoab Ali, Taha Alqahtani, Humood Al Shmrany, et al.
Scientific Reports|March 27, 2026
Advanced simulation and numerical evaluation of pharmaceutical solubility estimation under supercritical processing using artificial intelligence computationsAhmed H Albariqi, Rami M Alzhrani, Majed A Alghamdi, et al.
Biomaterials Advances|December 9, 2025
Enhanced permeability and retention (EPR) effect: Advances in nanomedicine for improved tumor targetingMohammad Sameer Khan, Taha Alqahtani, Humood Al Shmrany, et al.
Molecular Cancer|March 24, 2026
Multifunctional chitosan-doxorubicin nanocarriers: advancing targeted breast cancer chemotherapyGaurav Mishra, Muskan Leharwani, Taha Alqahtani, et al.
Critical Reviews in Oncology/Hematology|February 18, 2026
Mapping the molecular landscape of glioblastoma: Pathogenesis, therapeutic targets and bioactive interventionsAnkita Banerjee, Rajesh Kumar, Md Sadique Hussain, et al.
International Journal of Pharmaceutics|April 26, 2026
Gemcitabine-loaded nanoparticles for pancreatic cancer: from mechanistic innovations to clinical translationSonam Chosdon, Muskan Leharwani, Taha Alqahtani, et al.
Colloids and Surfaces. B, Biointerfaces|March 18, 2026
Mannose-decorated N-succinyl chitosan nanoparticle film: A novel approach for enhanced wound healingAsfi Rizwan, Urushi Rehman, Tenzin Sonam Dongsar, et al.
Molecular Cancer|November 13, 2025
Advances in PLGA-based polymeric nanocarriers for colorectal cancer therapy: overcoming chemoresistance through controlled delivery strategiesMohammad Sakib Khan, Urushi Rehman, Taha Alqahtani, et al.
Pageof 5

Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
International Journal of Pharmaceutics|February 1, 2026
Poly-ε-caprolactone nanoparticles in breast cancer therapy: bridging bench research and clinical potentialMuskan Leharwani, Urushi Rehman, Taha Alqahtani, et al.
Clinical and Translational Medicine|January 6, 2026
Stimulator of interferon genes (STING)-activating nanomedicines: Translating innate immune modulation into effective therapy for triple-negative breast cancerHarshita Singhai, Taha Alqahtani, Humood Al Shmrany, et al.
Drug Development Research|April 20, 2026
Artificial Intelligence in Drug Discovery and Development: Transforming Pharmaceutical InnovationMohd Shoab Ali, Taha Alqahtani, Humood Al Shmrany, et al.
Scientific Reports|March 27, 2026
Advanced simulation and numerical evaluation of pharmaceutical solubility estimation under supercritical processing using artificial intelligence computationsAhmed H Albariqi, Rami M Alzhrani, Majed A Alghamdi, et al.
Biomaterials Advances|December 9, 2025
Enhanced permeability and retention (EPR) effect: Advances in nanomedicine for improved tumor targetingMohammad Sameer Khan, Taha Alqahtani, Humood Al Shmrany, et al.
Molecular Cancer|March 24, 2026
Multifunctional chitosan-doxorubicin nanocarriers: advancing targeted breast cancer chemotherapyGaurav Mishra, Muskan Leharwani, Taha Alqahtani, et al.
Critical Reviews in Oncology/Hematology|February 18, 2026
Mapping the molecular landscape of glioblastoma: Pathogenesis, therapeutic targets and bioactive interventionsAnkita Banerjee, Rajesh Kumar, Md Sadique Hussain, et al.
International Journal of Pharmaceutics|April 26, 2026
Gemcitabine-loaded nanoparticles for pancreatic cancer: from mechanistic innovations to clinical translationSonam Chosdon, Muskan Leharwani, Taha Alqahtani, et al.
Colloids and Surfaces. B, Biointerfaces|March 18, 2026
Mannose-decorated N-succinyl chitosan nanoparticle film: A novel approach for enhanced wound healingAsfi Rizwan, Urushi Rehman, Tenzin Sonam Dongsar, et al.
Molecular Cancer|November 13, 2025
Advances in PLGA-based polymeric nanocarriers for colorectal cancer therapy: overcoming chemoresistance through controlled delivery strategiesMohammad Sakib Khan, Urushi Rehman, Taha Alqahtani, et al.
Pageof 5